LataMed AI (LMED) Cash from Financing Activities (2023 - 2026)

LataMed AI has disclosed Cash from Financing Activities across 4 years of filings, most recently posting $28384.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $28384.0, up 49.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $215160.0 (up 307.54% YoY), and the FY2025 annual result was $205791.0, up 207.91% from the prior year.
• Cash from Financing Activities came in at $28384.0 for Q1 2026 at LataMed AI, down from $158090.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $158090.0 in Q4 2025 to a low of $8104.0 in Q3 2023.
• The 4-year median for Cash from Financing Activities is $14854.0 (2025), against an average of $31871.7.
• Across the five-year window, Cash from Financing Activities plunged 76.82% in 2024 and soared 1544.54% in 2025, its largest moves.
• LataMed AI's Cash from Financing Activities stood at $41476.0 in 2023, then slumped by 76.82% to $9613.0 in 2024, then jumped by 1544.54% to $158090.0 in 2025, then tumbled by 82.05% to $28384.0 in 2026.
• The last three Cash from Financing Activities figures came in at $28384.0 (Q1 2026), $158090.0 (Q4 2025), and $13832.0 (Q3 2025), per Business Quant data.